San Carlos, United States
Celldom, Inc., founded in 2016, is at the forefront of next-generation cell analysis technology. The company's slogan, "Find and study cells that make diseases incurable," encapsulates its mission to revolutionize Biotechnology, Health Care, and Life Sciences industries. With its cutting-edge cloneXplorer platform and proprietary nanowell plates, Celldom uniquely integrates phenotypic and genomic data at an unprecedented scale, analyzing up to hundreds of thousands of cells per experiment.
The company's technology advances research, drug discovery, and development by identifying and characterizing rare cells pivotal in disease pathways, with a focus on oncology, immunology, and stem cell biology.
Headquartered in the United States, Celldom secured its last investment during a Seed Round on April 12, 2021, with notable investors such as TSVC and Corning. Positioned at the intersection of technology and healthcare, Celldom presents a compelling opportunity for investors seeking disruptive innovation in life sciences.
